Andrew Kees Roorda, MD
Gastroenterology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Roorda’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A101729 · Current
Licensed to practise in California · since 2007 · expires 2027-10-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$93,531
Medicare paid this office $93,531 for 423 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $17,300 | $137 |
| Return visit (30+ min) | 141 | $16,392 | $89 |
| Biopsy of large bowel using a flexible endoscope | 111 | $14,977 | $135 |
| New patient visit (45+ min) | 93 | $11,025 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 118 | $10,817 | $89 |
See all 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $17,300 | $137 |
| Return visit (30+ min) | 141 | $16,392 | $89 |
| Biopsy of large bowel using a flexible endoscope | 111 | $14,977 | $135 |
| New patient visit (45+ min) | 93 | $11,025 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 118 | $10,817 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | $5,625 | $194 |
| Short return visit (20+ min) | 77 | $4,602 | $55 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $2,589 | $113 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,283 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,931 | $67 |
| Short return visit | 18 | $540 | $30 |
Procedures Medicare counted
| Colonoscopy | 172 | More than 91% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 119 | More than 80% of doctors who do this |
Who their Medicare patients are
423 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 19% · Women 49% · Also on Medicaid 8% · Health risk score 1.39. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 41% · Diabetes 29% · Atrial fibrillation 29% · Chronic kidney disease 27% · Cancer 23% · Heart failure 20% · Depression 18% · COPD 13% · Dementia 10% · Stroke 10%.
The office billed $419,484, Medicare allowed $127,906 and paid $93,531; for 880 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 423 | 880 | 76 | 1.39 | $419,484 | $93,531 |
| 2023 | 427 | 929 | 77 | 1.50 | $439,669 | $106,393 |
| 2022 | 406 | 949 | 78 | 1.60 | $432,442 | $111,283 |
| 2021 | 393 | 885 | 77 | 1.78 | $399,137 | $107,000 |
| 2020 | 283 | 724 | 77 | 1.93 | $282,464 | $76,104 |
| 2019 | 486 | 1,158 | 78 | 1.80 | $495,096 | $131,212 |
| 2018 | 377 | 904 | 76 | 1.81 | $308,268 | $98,894 |
| 2017 | 469 | 1,092 | 77 | 2.04 | $381,103 | $121,402 |
| 2016 | 515 | 1,206 | 77 | 1.79 | $448,690 | $137,194 |
| 2015 | 495 | 1,119 | 75 | 1.71 | $461,447 | $132,365 |
| 2014 | 481 | 1,261 | 77 | 1.96 | $447,088 | $152,818 |
| 2013 | 335 | 1,244 | 76 | 1.97 | $445,517 | $136,130 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $21,134 | $150 |
| Return visit (30+ min) | 137 | $18,119 | $95 |
| New patient visit (45+ min) | 121 | $16,576 | $137 |
| Biopsy of large bowel using a flexible endoscope | 94 | $9,918 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $9,332 | $87 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 43 | $9,006 | $205 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,307 | $161 |
| Short return visit (20+ min) | 56 | $3,573 | $62 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,910 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,268 | $69 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,794 | $112 |
| Short return visit | 14 | $494 | $35 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $357 | $27 |
2022: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 158 | $28,850 | $174 |
| Return visit (30+ min) | 129 | $17,584 | $100 |
| Biopsy of large bowel using a flexible endoscope | 94 | $12,134 | $128 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $10,900 | $101 |
| New patient visit (45+ min) | 76 | $9,993 | $131 |
| Short return visit (20+ min) | 108 | $7,688 | $62 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 31 | $6,606 | $213 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,851 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,225 | $64 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,486 | $178 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,420 | $101 |
| Short return visit | 15 | $423 | $28 |
2021: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 164 | $31,266 | $179 |
| Return visit (30+ min) | 127 | $15,146 | $90 |
| Biopsy of large bowel using a flexible endoscope | 83 | $12,410 | $148 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $10,913 | $98 |
| New patient visit (45+ min) | 67 | $8,739 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $7,455 | $65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,511 | $226 |
| Short return visit (20+ min) | 48 | $3,316 | $68 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $3,020 | $168 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,431 | $162 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,264 | $105 |
2020: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $22,600 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $12,127 | $66 |
| Return visit (30+ min) | 103 | $11,575 | $78 |
| New patient visit (45+ min) | 52 | $6,110 | $118 |
| Biopsy of large bowel using a flexible endoscope | 40 | $5,624 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $5,059 | $105 |
| Short return visit (20+ min) | 44 | $2,605 | $53 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,731 | $157 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,659 | $111 |
2019: 13 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 210 | $38,780 | $175 |
| Short return visit (20+ min) | 164 | $16,203 | $67 |
| New patient visit (45+ min) | 94 | $13,697 | $146 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $11,148 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $10,387 | $65 |
| Biopsy of large bowel using a flexible endoscope | 89 | $10,190 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $8,872 | $216 |
| Diagnostic exam of large bowel using a flexible endoscope | 34 | $5,550 | $163 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $4,103 | $111 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,615 | $187 |
| Return visit (30+ min) | 17 | $1,603 | $94 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 13 | $1,032 | $79 |
| Injection beneath lining of large bowel using a flexible endoscope | 28 | $954 | $34 |
2018: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 156 | $28,870 | $173 |
| Short return visit (20+ min) | 134 | $11,755 | $61 |
| New patient visit (45+ min) | 78 | $10,495 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $9,576 | $63 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | $7,861 | $96 |
| Biopsy of large bowel using a flexible endoscope | 65 | $7,761 | $119 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $6,419 | $214 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,365 | $163 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,767 | $106 |
| Return visit (30+ min) | 18 | $1,752 | $97 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $344 | $29 |
2017: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 220 | $40,028 | $167 |
| Short return visit (20+ min) | 163 | $14,834 | $61 |
| New patient visit (45+ min) | 78 | $10,453 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 100 | $10,276 | $98 |
| Biopsy of large bowel using a flexible endoscope | 72 | $8,492 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $7,386 | $60 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $6,230 | $160 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,719 | $225 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $3,845 | $96 |
| Return visit (30+ min) | 39 | $3,272 | $84 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 15 | $1,126 | $75 |
2016: 13 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 219 | $39,874 | $171 |
| Short return visit (20+ min) | 151 | $15,776 | $65 |
| New patient visit (45+ min) | 110 | $15,474 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $11,972 | $62 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 109 | $11,475 | $104 |
| Biopsy of large bowel using a flexible endoscope | 73 | $9,058 | $118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $7,198 | $212 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,492 | $159 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $3,354 | $108 |
| Return visit (30+ min) | 35 | $3,256 | $93 |
| New patient visit (45+ min) | 23 | $2,532 | $110 |
| Insertion of stomach tube using a flexible endoscope | 12 | $2,038 | $170 |
| Short return visit (20+ min) | 19 | $855 | $41 |
2015: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 181 | $33,458 | $173 |
| Biopsy of large bowel using a flexible endoscope | 86 | $16,403 | $191 |
| New patient visit (45+ min) | 114 | $16,258 | $143 |
| Short return visit (20+ min) | 117 | $12,848 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $11,797 | $63 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $10,356 | $96 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 24 | $6,356 | $265 |
| Diagnostic exam of large bowel using a flexible endoscope | 32 | $5,839 | $182 |
| New patient visit (45+ min) | 38 | $4,319 | $114 |
| Return visit (30+ min) | 37 | $3,672 | $99 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,016 | $92 |
| Short return visit (20+ min) | 29 | $1,864 | $44 |
2014: 13 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 221 | $45,976 | $177 |
| New patient visit (45+ min) | 131 | $19,421 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 125 | $18,366 | $64 |
| Biopsy of large bowel using a flexible endoscope | 87 | $16,516 | $190 |
| Short return visit (20+ min) | 121 | $12,468 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 99 | $10,991 | $105 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $6,836 | $273 |
| New patient visit (45+ min) | 32 | $3,697 | $116 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $3,179 | $187 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,806 | $104 |
| Return visit (30+ min) | 25 | $2,404 | $96 |
| Insertion of stomach tube using a flexible endoscope | 12 | $2,168 | $181 |
| Short return visit (20+ min) | 18 | $781 | $43 |
2013: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 178 | $34,790 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 147 | $32,213 | $63 |
| New patient visit (45+ min) | 94 | $13,731 | $146 |
| Biopsy of large bowel using a flexible endoscope | 60 | $12,507 | $202 |
| Short return visit (20+ min) | 63 | $7,633 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $7,426 | $111 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $4,678 | $123 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $4,457 | $194 |
| Insertion of stomach tube using a flexible endoscope | 17 | $3,804 | $224 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,368 | $241 |
| Return visit (30+ min) | 26 | $2,680 | $99 |
| Injection beneath lining of large bowel using a flexible endoscope | 15 | $396 | $26 |
Drugs they prescribed that Part D paid
$99,345
Pharmacies billed $99,345 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 516) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
399 generic and 117 brand-name prescriptions · $99,345 in drug cost · 31 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 15 | $36,058 | $2,404 |
| Linzess | 27 | $15,176 | $562 |
| Dexlansoprazole Dr | 24 | $7,419 | $309 |
| Sod Sulf-Potass Sulf-Mag Sulf | 55 | $3,604 | $66 |
| Dexilant | 11 | $3,345 | $304 |
See all 10 drugs
| Creon | 15 | $36,058 | $2,404 |
| Linzess | 27 | $15,176 | $562 |
| Dexlansoprazole Dr | 24 | $7,419 | $309 |
| Sod Sulf-Potass Sulf-Mag Sulf | 55 | $3,604 | $66 |
| Dexilant | 11 | $3,345 | $304 |
| Pantoprazole | 125 | $2,022 | $16 |
| Lansoprazole | 49 | $1,710 | $35 |
| Hydrocortisone | 21 | $277 | $13 |
| Omeprazole | 44 | $257 | $6 |
| Famotidine | 16 | $195 | $12 |
Year by year
| 2024 | 516 | 208 | 0% (0) | 23% | $99,345 |
| 2023 | 507 | 170 | 0% (0) | 28% | $109,846 |
| 2022 | 492 | 193 | 0% (0) | 38% | $223,397 |
| 2021 | 426 | 162 | 0% (0) | 43% | $118,069 |
| 2020 | 377 | 132 | 0% (0) | 33% | $90,977 |
| 2019 | 507 | 155 | 0% (0) | 39% | $74,127 |
| 2018 | 316 | 116 | None | None | $35,178 |
| 2017 | 356 | 115 | 0% (0) | 31% | $72,185 |
| 2016 | 474 | 159 | None | 33% | $65,696 |
| 2015 | 438 | 169 | 0% (0) | 41% | $51,236 |
| 2014 | 271 | 117 | None | None | $25,605 |
| 2013 | 161 | 52 | 0% (0) | None | $26,558 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Creon | 20 | $40,412 | $2,021 |
| Linzess | 23 | $13,890 | $604 |
| Dexlansoprazole Dr | 25 | $9,787 | $391 |
| Dexilant | 11 | $3,669 | $334 |
| Clenpiq | 20 | $3,528 | $176 |
| Lubiprostone | 15 | $2,371 | $158 |
| Sod Sulf-Potass Sulf-Mag Sulf | 26 | $2,058 | $79 |
| Lansoprazole | 61 | $1,875 | $31 |
| Pantoprazole | 105 | $1,744 | $17 |
| Omeprazole | 36 | $410 | $11 |
| Gavilyte-G | 18 | $272 | $15 |
| Famotidine | 11 | $66 | $6 |
2022: 12 drugs
| Creon | 19 | $51,255 | $2,698 |
| Dexilant | 39 | $20,623 | $529 |
| Mesalamine Er | 16 | $10,167 | $635 |
| Linzess | 15 | $7,827 | $522 |
| Motegrity | 11 | $7,506 | $682 |
| Clenpiq | 44 | $7,295 | $166 |
| Suprep | 17 | $1,996 | $117 |
| Pantoprazole | 116 | $1,767 | $15 |
| Lansoprazole | 21 | $1,004 | $48 |
| Omeprazole | 43 | $397 | $9 |
| Peg 3350-Electrolyte | 13 | $157 | $12 |
| Famotidine | 17 | $135 | $8 |
2021: 10 drugs
| Xifaxan | 12 | $24,867 | $2,072 |
| Dexilant | 40 | $15,737 | $393 |
| Linzess | 31 | $13,248 | $427 |
| Clenpiq | 30 | $4,726 | $158 |
| Suprep | 42 | $4,646 | $111 |
| Mesalamine | 13 | $4,400 | $338 |
| Pantoprazole | 90 | $2,304 | $26 |
| Esomeprazole Magnesium | 12 | $938 | $78 |
| Omeprazole | 43 | $773 | $18 |
| Famotidine | 28 | $466 | $17 |
2020: 8 drugs
| Dexilant | 29 | $13,472 | $465 |
| Linzess | 12 | $7,152 | $596 |
| Apriso | 11 | $5,303 | $482 |
| Mesalamine Er | 11 | $3,958 | $360 |
| Suprep | 35 | $3,669 | $105 |
| Pantoprazole | 96 | $2,154 | $22 |
| Sucralfate | 14 | $1,450 | $104 |
| Omeprazole | 40 | $853 | $21 |
2019: 8 drugs
| Relistor | 68 | $28,834 | $424 |
| Dexilant | 17 | $7,310 | $430 |
| Suprep | 72 | $7,152 | $99 |
| Amitiza | 12 | $4,485 | $374 |
| Pantoprazole | 103 | $2,019 | $20 |
| Omeprazole | 51 | $1,521 | $30 |
| Ondansetron Odt | 17 | $435 | $26 |
| Ranitidine | 21 | $128 | $6 |
2018: 6 drugs
| Dexilant | 20 | $6,686 | $334 |
| Relistor | 13 | $4,788 | $368 |
| Suprep | 50 | $4,694 | $94 |
| Omeprazole | 49 | $1,274 | $26 |
| Pantoprazole | 61 | $1,127 | $18 |
| Ondansetron Odt | 13 | $436 | $34 |
2017: 8 drugs
| Linzess | 15 | $5,306 | $354 |
| Dexilant | 13 | $3,770 | $290 |
| Suprep | 24 | $2,136 | $89 |
| Mercaptopurine | 12 | $1,244 | $104 |
| Omeprazole | 51 | $1,019 | $20 |
| Pantoprazole | 55 | $870 | $16 |
| Peg 3350-Electrolyte | 18 | $261 | $14 |
| Ranitidine | 15 | $123 | $8 |
2016: 10 drugs
| Linzess | 25 | $8,007 | $320 |
| Amitiza | 21 | $6,942 | $331 |
| Nexium | 12 | $3,025 | $252 |
| Esomeprazole Magnesium | 14 | $1,687 | $120 |
| Omeprazole | 101 | $1,440 | $14 |
| Peg 3350-Electrolyte | 35 | $547 | $16 |
| Pantoprazole | 43 | $419 | $10 |
| Gavilyte-N | 19 | $324 | $17 |
| Ranitidine | 22 | $219 | $10 |
| Furosemide | 11 | $25 | $2 |
2015: 10 drugs
| Budesonide Ec | 12 | $7,037 | $586 |
| Amitiza | 21 | $6,746 | $321 |
| Nexium | 23 | $5,893 | $256 |
| Omeprazole | 90 | $1,100 | $12 |
| Peg 3350-Electrolyte | 39 | $694 | $18 |
| Gavilyte-N | 22 | $410 | $19 |
| Pantoprazole | 21 | $204 | $10 |
| Spironolactone | 18 | $194 | $11 |
| Ranitidine | 28 | $175 | $6 |
| Furosemide | 16 | $37 | $2 |
2014: 7 drugs
| Nexium | 19 | $7,252 | $382 |
| Dexilant | 16 | $4,178 | $261 |
| Ursodiol | 17 | $1,687 | $99 |
| Peg-3350 | 27 | $508 | $19 |
| Omeprazole | 25 | $361 | $14 |
| Ranitidine | 25 | $261 | $10 |
| Pantoprazole | 15 | $148 | $10 |
2013: 4 drugs
| Nexium | 11 | $5,417 | $492 |
| Dexilant | 12 | $2,220 | $185 |
| Ursodiol | 13 | $408 | $31 |
| Ranitidine | 16 | $130 | $8 |
Money from drug and device companies
$429 in 2025
| 2025 | 10 | 20 | None | $429 |
| 2024 | 9 | 18 | None | $384 |
| 2023 | 6 | 21 | None | $460 |
| 2022 | 8 | 11 | None | $290 |
| 2021 | 3 | 4 | None | $65 |
| 2020 | 6 | 11 | None | $225 |
| 2019 | 11 | 41 | None | $737 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Creon | $117 | 5 payments
|
| Janssen Biotech | Tremfya | $80 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $69 | 3 payments
|
| QOL Medical | Sucraid | $32 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $27 | 1 payment
|
| Braintree Laboratories | Suflave | $24 | 1 payment
|
See all 20 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-21 | Xifaxan | $24 |
| QOL Medical | Meals · 2025-12-17 | Sucraid | $32 |
| Pfizer | Meals · 2025-12-10 | Velsipity | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-12-03 | Rezdiffra | $27 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $19 |
| Exact Sciences | Meals · 2025-10-08 | The Cologuard Plus Collection Kit | $19 |
| Janssen Biotech | Meals · 2025-09-24 | Tremfya | $23 |
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $19 |
| Braintree Laboratories | Meals · 2025-08-20 | Suflave | $24 |
| Phathom Pharmaceuticals | Meals · 2025-08-13 | Voquezna | $19 |
| Phathom Pharmaceuticals | Meals · 2025-08-13 | Voquezna | $2 |
| Abbvie | Meals · 2025-07-30 | Rinvoq | $17 |
| Abbvie | Meals · 2025-07-16 | Creon | $27 |
| Celltrion USA | Meals · 2025-07-03 | Vegzelma | $19 |
| Abbvie | Meals · 2025-05-15 | Linzess | $21 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-12 | Xifaxan | $24 |
| Janssen Biotech | Meals · 2025-04-09 | Tremfya | $16 |
| Abbvie | Meals · 2025-03-27 | Creon | $33 |
| Janssen Biotech | Meals · 2025-03-05 | Tremfya | $22 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-01-23 | Xifaxan | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $384
| Janssen Biotech | Tremfya | $101 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $65 | 3 payments
|
| Abbvie | Creon | $52 | 2 payments
|
| Celltrion USA | Vegzelma | $44 | 2 payments
|
| Lilly USA | Omvoh | $34 | 2 payments
|
| Olympus America | Endoclot Phs | $24 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $22 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $21 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $21 | 1 payment
|
2023: $460
| Merck Sharp & Dohme | Dificid | $137 | 6 payments
|
| AbbVie | Viberzi | $112 | 5 payments
|
| Janssen Biotech | Stelara | $96 | 5 payments
|
| QOL Medical | Sucraid | $61 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $41 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $14 | 1 payment
|
2022: $290
| Johnson & Johnson Vision Care | Amo Phaco Needle | $78 | 1 payment
|
| Janssen Biotech | Stelara | $55 | 3 payments
|
| Abbvie | Linzess | $51 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $28 | 1 payment
|
| QOL Medical | Sucraid | $27 | 1 payment
|
| Braintree Laboratories | Sutab | $24 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
| PENTAX of America | C2 Cryoballoon | $12 | 1 payment
|
2021: $65
| AbbVie | Linzess | $34 | 2 payments
|
| Cook Medical | Hemospray | $16 | 1 payment
|
| Janssen Biotech | Stelara | $15 | 1 payment
|
2020: $225
| Takeda Pharmaceuticals U.S.A. | Entyvio | $83 | 4 payments
|
| Janssen Biotech | Stelara | $49 | 2 payments
|
| Alfasigma USA | None | $39 | 2 payments
|
| AbbVie | Humira | $23 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $15 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $15 | 1 payment
|
2019: $737
| Takeda Pharmaceuticals U.S.A. | Entyvio | $213 | 11 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $121 | 7 payments
|
| Merck Sharp & Dohme | Dificid | $77 | 5 payments
|
| AbbVie | Humira | $77 | 4 payments
|
| Janssen Biotech | Stelara | $56 | 3 payments
|
| Allergan | Linzess | $51 | 3 payments
|
| Ferring Pharmaceuticals | Clenpiq | $46 | 3 payments
|
| Ironwood Pharmaceuticals | Linzess | $38 | 2 payments
|
| Daiichi Sankyo | Injectafer | $20 | 1 payment
|
| Pfizer | Inflectra | $19 | 1 payment
|
| Shionogi | Mulpleta | $19 | 1 payment
|
Professional record
- NPI
- 1881861540
- Licence
- CA A101729, WV 23265California A101729: Current · expires 2027-10-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WV 3810020465
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2690 Hanover St, Palo Alto, CA, 94304
- NPI first listed
- 2008-05-13
- NPI last updated
- 2013-06-18
This is when the NPI record was last certified, not a medical board exam.